Summary
We have released the latest research "The Future of the Pharmaceutical Packaging Industry-Emerging Economies Poised to Capitalize on Increasing Demand" which provides insights on the global pharmaceutical packaging market and giving information on market forecasts until 2015. Further, the geographical distribution of pharmaceutical packaging manufacturers across key geographies such as the US, the top five countries in the European region, and Japan are also provided in the report. Key cost and developmental issues are also addressed. The report provides analysis on the competitive landscape including the benchmarking of top companies. Finally, key trends analysis on mergers and acquisitions, and licensing agreements involving pharmaceutical packaging is detailed.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by our team of industry experts.
Scope
The scope of this report includes:
* Detailed market characterization including market size, technology adoption and forecasts until 2015.
* Data and analysis on the global pharmaceutical packaging market in the leading geographies of the world-the US, the UK, Germany, France, Italy, Spain, and Japan, and the emerging geographies-
* Analysis and review of the key events and milestones that will impact the future of the global e-clinical trial solutions market. Each trend is independently researched to provide qualitative analysis of its implications.
* Insightful review of key industry drivers, restraints and challenges which are likely to impact the global pharmaceutical packaging market in the long run.
* The report also covers information on the leading market players and the competitive landscape. Key companies covered include are Schott AG, Gerresheimer AG, Duran Group, Nypro Inc., Rexam PLC, Corning Incorporated, and Facet.
Reasons to buy
The report will enhance your decision making capability and will allow you to:
* Develop business strategies by understanding the trends shaping and driving the global pharmaceutical packaging market.
* Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the pharmaceutical packaging market in the future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in global pharmaceutical packaging market landscape?-Identify, understand and capitalize.
Table Of Contents
1 The Future of the Pharmaceutical Packaging Industry- Executive Summary
2 Table Of Contents
2.1 List Of Tables
2.2 List Of Figures
3 Introduction
3.1 Report Guidance
4 The Future of the Pharmaceutical Packaging Industry- Industry Overview
4.1 Introduction
4.1.1 Key Aspects of Packaging
4.2 Industry Segments in Pharmaceutical Packaging
4.2.1 Blister Packaging
4.2.2 Plastic Bottles
4.2.3 Labels and Accessories
4.2.4 Drug Delivery Devices
4.2.5 Pouches and Strip Packs
4.2.6 Caps and Closures
4.2.7 Secondary Containers
4.2.8 Others
5 The Future of the Pharmaceutical Packaging Industry- Market Characterization
5.1 Market Forecasts
6 The Future of Pharmaceutical Packaging-Market Drivers, Challenges and Key Trends
6.1 Growth Drivers
6.1.1 Emerging Countries Show Immense Growth Potential for Global Pharmaceutical Industry
6.1.2 Increasing Usage of Biologics Will Require Innovative Packaging Solutions
6.1.3 Ageing Population Will Drive Demand for Pharmaceutical Products
6.1.4 Patent Expiries of Prescription Drugs Will Boost the Usage of Generics
6.2 Market Challenges
6.2.1 Producing Consistent Quality in the Market is a Challenge for Pharmaceutical Packaging Supplier
6.2.2 Availability and Price Volatility of Raw Materials is a Conundrum for Pharmaceutical Packaging Companies
6.2.3 Changes in Health Safety Regulations Are Frequent and Have Serious Effects on Sales of Pharmaceutical Packaging Suppliers
6.3 Key Industry Trends
6.3.1 Changes in Procurement Strategy will Drive Value across the Business Due to the Impact of Recession
6.3.2 Quality is the Critical Success Factor for Selecting a Packaging Supplier
6.3.3 Spending On Pharmaceutical Packaging Is Expected To Increase over the Next 12 Months
6.3.4 Review Pricing as an Business Opportunity is the Most Preferred Strategy
7 The Future of the Pharmaceutical Packaging Industry- Geographic Landscape
7.1 Geographical Split
7.2 Geographical Trends
7.2.1 Pharmaceutical Packaging in APAC Region will Grow Faster than the US and Europe
7.2.2 Growth in the Packaging Industry in Emerging Nations Will be Faster than the Developed Nations
7.3 Emerging Markets
7.3.1 China
7.3.1.1 Overview
7.3.1.2 Porter's Diamond
7.3.1.3 Trends
7.3.2 India
7.3.2.1 Overview
7.3.2.2 Porter's Diamond
7.3.2.3 Trends
7.3.3 Brazil
7.3.3.1 Overview
7.3.3.2 Porter's Diamond
7.3.3.3 Trends
7.3.4 Russia
7.3.4.1 Overview
7.3.4.2 Porter's Diamond
7.3.4.3 Trends
8 The Future of the Pharmaceutical Packaging Industry- Regulatory Framework
8.1 International Standards for Pharmaceutical Packaging
8.1.1 PS 9000:2001 - Pharmaceutical Packaging Materials
8.1.2 ISO 15378: 2006
8.2 National Guidelines for Pharmaceutical Packaging
8.2.1 Regulatory Framework in the US
8.2.1.1 Guideline on Container Closure Systems
8.2.1.2 US Pharmacopeia
8.2.1.3 Guideline on RFID and Changes in Packaging Material
8.2.2 Regulatory Framework in Europe
8.2.2.1 EMEA Good Manufacturing Practices
8.2.2.2 EMEA Quality Guidelines (Volume 3)
8.2.2.3 EMEA Regulatory Guidelines (Volume 2B)
8.2.2.4 European Pharmacopoeia
8.2.3 Regulatory Framework in Asia Pacific
8.2.3.1 Overview
9 The Future of the Pharmaceutical Packaging Industry- Competitive Landscape
9.1 Rexam
9.1.1 Business Description
9.1.2 Financial Performance
9.1.3 Deals and Alliances
9.2 Schott
9.2.1 Business Description
9.2.2 Financial Performance
9.2.3 Deals and Alliances
9.3 Alcan Packaging
9.3.1 Business Description
9.3.2 Deals and Alliances
9.4 Nypro
9.4.1 Business Description
9.4.2 Financial Performance
9.5 Consort Medical
9.5.1 Business Description
9.5.2 Financial Performance
9.6 Becton Dickinson
9.6.1 Business Description
9.6.2 Financial Performance
9.6.3 Deals and Alliances
9.7 Gerresheimer
9.7.1 Business Description
9.7.2 Financial Performance
9.7.3 Deals and Alliances
9.8 West Pharmaceutical Services
9.8.1 Business Description
9.8.2 Financial Performance
9.8.3 Deals and Alliances
9.9 AMCOR
9.9.1 Business Description
9.9.2 Financial Performance
9.10 Ypsomed
9.10.1 Business Description
9.10.2 Financial Performance
9.11 Bormioli Rocco
9.11.1 Business Description
9.12 Duran
9.12.1 Business Description
9.13 Catalent
9.13.1 Business Description
9.13.2 Deals and Alliances
9.14 Meadwestvaco
9.14.1 Business Description
10 The Future of the Pharmaceutical Packaging Industry- Strategic Consolidations
10.1 Overview
11 The Future of the Pharmaceutical Packaging Industry- Appendix
11.1 Market Definitions
11.2 Abbreviations
11.3 Research Methodology
11.3.1 Coverage
11.3.2 Secondary Research
11.3.3 Primary Research
11.3.4 Expert Panel Validation
11.4 Contact Us
11.5 Disclaimer
11.6 Sources
1.1 List of Tables
Table 1: Pharmaceutical Packaging Market, Global, Revenue Forecasts, 2008-2015
Table 2: Pharmaceutical Packaging Market, Global, Regulatory Guidelines in Asia Pacific, 2009
1.1 List of Figures
...
